CellaVision Balance Sheet Health
Financial Health criteria checks 5/6
CellaVision has a total shareholder equity of SEK758.8M and total debt of SEK56.1M, which brings its debt-to-equity ratio to 7.4%. Its total assets and total liabilities are SEK974.1M and SEK215.4M respectively. CellaVision's EBIT is SEK180.8M making its interest coverage ratio 80. It has cash and short-term investments of SEK167.0M.
Key information
7.4%
Debt to equity ratio
kr56.09m
Debt
| Interest coverage ratio | 80x |
| Cash | kr166.98m |
| Equity | kr758.76m |
| Total liabilities | kr215.35m |
| Total assets | kr974.12m |
Recent financial health updates
Is CellaVision (STO:CEVI) A Risky Investment?
Jan 13
CellaVision (STO:CEVI) Seems To Use Debt Rather Sparingly
Sep 23CellaVision (STO:CEVI) Could Easily Take On More Debt
Apr 28Recent updates
CellaVision (STO:CEVI) Is Due To Pay A Dividend Of SEK2.25
Apr 13CellaVision AB (publ)'s (STO:CEVI) Intrinsic Value Is Potentially 46% Above Its Share Price
Apr 09CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25
Mar 28CellaVision's (STO:CEVI) Dividend Will Be SEK2.25
Mar 14CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25
Feb 29After Leaping 28% CellaVision AB (publ) (STO:CEVI) Shares Are Not Flying Under The Radar
Feb 16CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25
Feb 12Earnings Beat: CellaVision AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 10CellaVision's (STO:CEVI) Returns On Capital Not Reflecting Well On The Business
Dec 13Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?
Sep 14Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)
Aug 22CellaVision (STO:CEVI) Is Reinvesting At Lower Rates Of Return
Jun 17CellaVision's (STO:CEVI) Upcoming Dividend Will Be Larger Than Last Year's
May 07Estimating The Fair Value Of CellaVision AB (publ) (STO:CEVI)
Apr 19CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.25
Apr 05CellaVision (STO:CEVI) Is Paying Out A Larger Dividend Than Last Year
Mar 04CellaVision AB (publ) (STO:CEVI) Analysts Are More Bearish Than They Used To Be
Feb 11Is CellaVision (STO:CEVI) A Risky Investment?
Jan 13Is CellaVision AB (publ) (STO:CEVI) Potentially Undervalued?
Dec 13CellaVision (STO:CEVI) Seems To Use Debt Rather Sparingly
Sep 23CellaVision (STO:CEVI) May Have Issues Allocating Its Capital
Aug 16Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)
Aug 02We Ran A Stock Scan For Earnings Growth And CellaVision (STO:CEVI) Passed With Ease
Jun 27What Is CellaVision AB (publ)'s (STO:CEVI) Share Price Doing?
May 31CellaVision (STO:CEVI) Could Easily Take On More Debt
Apr 28Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)
Apr 07Some Investors May Be Worried About CellaVision's (STO:CEVI) Returns On Capital
Mar 26If You Like EPS Growth Then Check Out CellaVision (STO:CEVI) Before It's Too Late
Mar 08Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?
Feb 17Is CellaVision AB (publ) (STO:CEVI) Worth kr320 Based On Its Intrinsic Value?
Dec 25Financial Position Analysis
Short Term Liabilities: CEVI's short term assets (SEK392.5M) exceed its short term liabilities (SEK122.0M).
Long Term Liabilities: CEVI's short term assets (SEK392.5M) exceed its long term liabilities (SEK93.3M).
Debt to Equity History and Analysis
Debt Level: CEVI has more cash than its total debt.
Reducing Debt: CEVI's debt to equity ratio has increased from 0% to 7.4% over the past 5 years.
Debt Coverage: CEVI's debt is well covered by operating cash flow (444.3%).
Interest Coverage: CEVI's interest payments on its debt are well covered by EBIT (80x coverage).